atomoxetine hydrochloride has been researched along with pozanicline in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abi-Saab, WM; Apostol, G; Bensman, L; Childress, A; Garimella, TS; Gault, LM; Hall, CM; Kratochvil, CJ; Olson, E; Robieson, WZ; Saltarelli, MD; Wilens, TE | 1 |
| Franke, AG; Huss, M; Konrad, A; Lieb, K | 1 |
1 review(s) available for atomoxetine hydrochloride and pozanicline
| Article | Year |
|---|---|
[Stimulant and non-stimulant medication in current and future therapy for ADHD].
Topics: Adrenergic alpha-2 Receptor Agonists; Adult; Amphetamines; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Benzhydryl Compounds; Central Nervous System Stimulants; Child; Dextroamphetamine; Fatty Acids, Omega-3; Guanfacine; Histamine Agonists; Humans; Isoxazoles; Lisdexamfetamine Dimesylate; Memantine; Methylphenidate; Modafinil; Off-Label Use; Propylamines; Pyridines; Pyrrolidines; Receptors, AMPA | 2012 |
1 trial(s) available for atomoxetine hydrochloride and pozanicline
| Article | Year |
|---|---|
Safety and efficacy of ABT-089 in pediatric attention-deficit/hyperactivity disorder: results from two randomized placebo-controlled clinical trials.
Topics: Adrenergic Uptake Inhibitors; Adult; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Double-Blind Method; Drug Monitoring; Female; Humans; Male; Nicotinic Agonists; Propylamines; Psychiatric Status Rating Scales; Pyridines; Pyrrolidines; Treatment Outcome | 2011 |